DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

0.8397
Delayed Data
As of 3:45pm ET
 -0.0004 / -0.05%
Today’s Change
0.78
Today|||52-Week Range
2.84
-22.96%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +1,329.08% increase from the last price of 0.84.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
$0.00
Reporting Date
Aug 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 38.46%
 
 
 
 
 
 
Growthannually 31.76%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.